Biolinq secures $100M in Series C funding for its intradermal glucose sensor to improve metabolic health in type 2 diabetes, led by Alpha Wave Ventures.
Amount Raised
$100 Million
Round Type
Series C
San DiegoBiotechnologyHealth CareMedical DeviceInvestors
Description
Biolinq announced the successful completion of a $100 million Series C funding round to advance its wearable biosensor technology for type 2 diabetes. Alpha Wave Ventures led the round with support from various existing investors. The funding will help Biolinq pursue regulatory approval and enhance its commercial readiness efforts. The company's glucose sensor is still under investigation and not yet approved by the FDA.
Quick answer
Biolinq raised $100 Million in a Series C round, dated April 22, 2025. Investors: Alpha Wave Ventures, Taisho Pharmaceutical, Hikma Ventures, LifeSci Venture Partners, Rivervest Venture Partners, Axa Im Alts, M Ventures and Features Capital. Biolinq is based in San Diego, California, United States.
- How much did Biolinq raise?
- Biolinq raised $100 Million in a Series C round on April 22, 2025.
- Who invested in Biolinq?
- Alpha Wave Ventures, Taisho Pharmaceutical, Hikma Ventures, LifeSci Venture Partners, Rivervest Venture Partners, Axa Im Alts, M Ventures and Features Capital are named as investors in this round.
- What does Biolinq do?
- Biolinq is a healthcare technology company pioneering precision multi-analyte wearable sensors to improve metabolic health.
- Where is Biolinq based and how big is it?
- Biolinq is based in San Diego, California, United States. Fundz records about 107 employees.
- Who are the decision-makers at Biolinq?
- Fundz holds 1 contact at Biolinq, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical Device and Biotechnology around the same time
Companies in the same sectors as Biolinq that raised within 45 days of this round, from Fundz verified event records.
- MED-X raised $250K on June 3, 2025.
- Femasys raised $1.4M on June 2, 2025.
- ClearNote Health raised $22M on May 27, 2025.
- Senseonics raised $20M on May 20, 2025.
- Flyte Aviation, Inc. raised $1.5M (Private Equity) on May 12, 2025.
- Chipiron raised $17M (Series A) on May 8, 2025.
Who to call at Biolinq, and when
A new round usually means Biolinq is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Biolinq raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biolinq, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biolinq. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biolinq raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Biolinq raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.